Category:

International News

Latest

Japan to suffer minimum $10bn economic loss from Typhoon Hagibis, according to Aon catastrophe report

Steve Bowen, Director and Meteorologist within Aon’s Impact Forecasting team, said: “Vulnerabilities around tropical cyclones, flooding, and wildfires were again exposed during October. Events such as Typhoon Hagibis in Japan and wildfires in California served as a reminder of the repetitive, or clustering, nature of certain perils on a year-to-year basis that can often be hard to predict. With ample exposure located in high-risk locations all around the world, it becomes increasingly important to utilize the latest tools available to better prepare for future weather and climate-related scenarios in both mature and developing markets.”

read more

Aon & partners deliver pay-outs with first Blockchain-Based Agricultural Insurance Policies for smallholder farmers in Sri Lanka

After the coordinated launch earlier this year with 200 farmers enrolled who are at risk of losing their crops due to extreme weather, the system made pay-outs to farmers in this initial operations phase. The companies will now move forward by seeking solutions to some of the challenges identified in the next phase of the project as cropping season starts in November. The main goals of this follow-on phase are to refine the system’s efficiency and scale the number of farmers who will benefit from the microinsurance

read more

Wall Street increasingly weighs risk from climate change

The increase in wildfires has prompted underwriters, such as Hiscox Ltd to incorporate new risks models and stop insuring some clients in high-risk areas such as California.Overall, 10% of insurers refused to renew policies in wildfire-prone areas in California in 2018, according to the California Department of Insurance.

read more

New FDA warning letters show Indian drug makers’ quality concerns persist

The latest regulatory crackdown shows US regulator’s stance is hardening toward lapses in quality control even as it seeks cheaper drugs to contain health care costs. Indian pharmaceutical factories collectively produce about 40 per cent of the American generic drug supply and have been faulted in the past by the FDA for everything from lax documentation to open toilet drains and malfunctioning equipment.

read more